Navigation Links
Cyberkinetics Requests FDA to Sell Nerve Growth Stimulation System

Cyberkinetics, Inc, winner of the Medgadget "Most Sci-Fi Sounding Company Name" Award, has asked the FDA for permission to market// their Andara OFS nerve growth stimulation system.

According to Cyberkinetics, “Cyberkinetics' Andara? OFS? System consists of a battery-powered device about the size of a cardiac pacemaker with six electrical leads. Three of the leads are attached to the vertebrae at a distance of two disk-segments above the area of injury, and three are attached to the vertebrae at a distance of two disk-segments below the injury. By applying an oscillating, low-voltage, direct current of electricity to the areas above and below a spinal cord injury, the Andara? OFS? System creates an electrical field that surrounds the injury and stimulates the nerves surrounding the spinal cord to grow and form new connections that can restore sensory and motor function. The Andara? OFS? System is an investigational device. It is not currently approved for sale and is available only through participation in a clinical study.

Cyberkinetics has filed an application for Humanitarian Use Device status from the FDA. If the application is successful, Cyberkinetics could market the device commercially in late 2007.

Basically, the new humanitarian exemption would mean that they could actually sell the device, rather than only use it through clinical trials.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Canadian Street Prostitutes Requests Protection
2. New Zealand Requests Details from Britain about ‘Black Sheep
3. Patients Requests for Antidepressants can Influence Physician Evaluation of Depression
4. FDA Requests Label Change for All Sleep Disorder Drug Products
5. Epilepsy Drug Helps Diabetic Nerve Damage
6. World’s First Nerve Stem Cells Produced
7. Children With Epilepsy Can Be Treated With Nerve Stimulation
8. FDA Approved Nerve-Stimulation Therapy Now Available In New York
9. Doctors Finish Mother-To-Son Nerve Surgery
10. Stem Cells From Hair Follicle To Repair Nerve Damage
11. Nerve regeneration for Spinal cord injuries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: